Relationships between Chromosome 7 Gain, MET Gene Copy Number Increase and MET Protein Overexpression in Chinese Papillary Renal Cell Carcinoma Patients
Authors:
Open Access
- 4 December 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (12) , e0143468
Abstract
To investigate the relationships between Chromosome 7 gain, mesenchymal-epithelial transition factor (MET) gene copy number increase and MET protein overexpression in Chinese patients with papillary renal cell carcinoma (PRCC), immunohistochemistry (IHC), immunofluorescence (IF) and fluorescence in situ hybridization (FISH) were performed on 98 formalin-fixed, paraffin-embedded (FFPE) PRCC samples. Correlations between MET gene copy number increase, Chromosome 7 gain and MET protein overexpression were analyzed statistically. A highly significant correlation was observed between the percentage of tumor cells with MET gene copy number ≥3 and CEP7 copy number ≥3 (R2 = 0.90, p5 using combined IF and FISH methodology. Overall, this study provides evidence that Chromosome 7 gain drives MET gene copy number increase in PRCC tumors, and appears to subsequently lead to an increase in MET protein overexpression in these tumor cells. This supports MET activation as a potential therapeutic target in sporadic PRCC.Keywords
This publication has 32 references indexed in Scilit:
- c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinomaAnnals of Oncology, 2012
- Novel germline c-MET mutation in a family with hereditary papillary renal carcinomaFamilial Cancer, 2012
- Trisomy 7 and 17 mark papillary renal cell tumours irrespectively of variation of the phenotypeJournal of Clinical Pathology, 2009
- Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markersBMC Cancer, 2009
- MET Gene Copy Number in Non-small Cell Lung Cancer: Molecular Analysis in a Targeted Tyrosine Kinase Inhibitor Naïve CohortJournal of Thoracic Oncology, 2008
- 2004 WHO Classification of the Renal Tumors of the AdultsEuropean Urology, 2006
- MET Expression in Sporadic Renal Cell CarcinomasJournal of Korean Medical Science, 2006
- Numerical chromosomal aberrations in papillary renal cortical tumorsVirchows Archiv, 2001
- Novel mutations of the MET proto-oncogene in papillary renal carcinomasOncogene, 1999
- Papillary Renal Cell CarcinomaDiagnostic Molecular Pathology, 1996